Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Cancers
|
October 29, 2025
Beyond Morphology: Quantitative MR Relaxometry in Pulmonary Lesion Classification
Markus Graf, Alexander W Marka, Andreas Wachter, et al.
BMC Cardiovascular Disorders
|
March 7, 2019
Strain-encoded cardiac magnetic resonance imaging: a new approach for fast estimation of left ventricular function
Tomas Lapinskas, Victoria Zieschang, Jennifer Erley, et al.
Diagnostics (Basel, Switzerland)
|
December 16, 2020
Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition
Josefine Graef, Carolin Senger, Christoph Wetz, et al.
Scientific Reports
|
May 29, 2021
Author Correction: Hyperpolarized <sup>13</sup>C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC
Elisabeth Bliemsrieder, Georgios Kaissis, Martin Grashei, et al.
Scientific Reports
|
January 14, 2021
Hyperpolarized <sup>13</sup>C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC
Elisabeth Bliemsrieder, Georgios Kaissis, Martin Grashei, et al.
NPJ Digital Medicine
|
April 25, 2022
Author Correction: Federated deep learning for detecting COVID-19 lung abnormalities in CT: a privacy-preserving multinational validation study
Qi Dou, Tiffany Y So, Meirui Jiang, et al.
NPJ Digital Medicine
|
March 30, 2021
Federated deep learning for detecting COVID-19 lung abnormalities in CT: a privacy-preserving multinational validation study
Qi Dou, Tiffany Y So, Meirui Jiang, et al.
International Journal of Cancer
|
September 19, 2022
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial
Agne Krilaviciute, Peter Albers, Jale Lakes, et al.
European Urology
|
May 15, 2024
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial
Agne Krilaviciute, Rudolf Kaaks, Petra Seibold, et al.
European Urology Oncology
|
October 8, 2023
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer
Agne Krilaviciute, Nikolaus Becker, Jale Lakes, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Cancers
|
October 29, 2025
Beyond Morphology: Quantitative MR Relaxometry in Pulmonary Lesion Classification
Markus Graf, Alexander W Marka, Andreas Wachter, et al.
BMC Cardiovascular Disorders
|
March 7, 2019
Strain-encoded cardiac magnetic resonance imaging: a new approach for fast estimation of left ventricular function
Tomas Lapinskas, Victoria Zieschang, Jennifer Erley, et al.
Diagnostics (Basel, Switzerland)
|
December 16, 2020
Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition
Josefine Graef, Carolin Senger, Christoph Wetz, et al.
Scientific Reports
|
May 29, 2021
Author Correction: Hyperpolarized <sup>13</sup>C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC
Elisabeth Bliemsrieder, Georgios Kaissis, Martin Grashei, et al.
Scientific Reports
|
January 14, 2021
Hyperpolarized <sup>13</sup>C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC
Elisabeth Bliemsrieder, Georgios Kaissis, Martin Grashei, et al.
NPJ Digital Medicine
|
April 25, 2022
Author Correction: Federated deep learning for detecting COVID-19 lung abnormalities in CT: a privacy-preserving multinational validation study
Qi Dou, Tiffany Y So, Meirui Jiang, et al.
NPJ Digital Medicine
|
March 30, 2021
Federated deep learning for detecting COVID-19 lung abnormalities in CT: a privacy-preserving multinational validation study
Qi Dou, Tiffany Y So, Meirui Jiang, et al.
International Journal of Cancer
|
September 19, 2022
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trial
Agne Krilaviciute, Peter Albers, Jale Lakes, et al.
European Urology
|
May 15, 2024
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial
Agne Krilaviciute, Rudolf Kaaks, Petra Seibold, et al.
European Urology Oncology
|
October 8, 2023
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer
Agne Krilaviciute, Nikolaus Becker, Jale Lakes, et al.
Page
of 6